Tutorials
Sanofi SA logo

Sanofi SA

€ 97.51 (+1.22%) Aug 5
On watch
P/E:
18.43
P/B:
1.72
Market Cap:
€ 121.93B ($ 124.17B)
Enterprise V:
€ 136.27B ($ 138.77B)
Volume:
1.42M
Avg Vol (2M):
1.88M
Also Trade In:
Volume:
1.42M
Market Cap €:
121.93B
Market Cap $:
124.17B
PE Ratio:
18.43
Avg Vol (2-Month):
1.88M
Enterprise Value €:
136.27B
Enterprise Value $:
138.77B
PB Ratio:
1.72
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Financials (Next Earnings Date:2022-10-28)

XPAR:SAN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 42,039
EPS (TTM) (€) 5.29
Beta 0.46
Volatility % 14.35
14-Day RSI 48.55
14-Day ATR (€) 2.330201
20-Day SMA (€) 98.3565
12-1 Month Momentum % 14.72
52-Week Range (€) 80.510172 - 106.080482
Shares Outstanding (Mil) 1,250.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sanofi SA Filings

Document Form Filing Date
No Filing Data